Kiyomitsu Kuninaga

PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade.

Young Hak Kim, T. Hirai, R. Itotani, 2020, European journal of cancer.

Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer

Young Hak Kim, S. Muro, T. Hirai, 2016, Scientific Reports.

Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1‐rearranged lung cancer

W. Aoki, R. Itotani, Y. Sakamori, 2022, Cancer science.